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Comprehensive Review
Introduction
 Individuals with schizophrenia frequently achieve re-
mission of hallmark symptoms of psychosis.  However, few 
achieve true recovery.  Instead, individuals with schizo-
phrenia experience chronic disability in many domains of 
functioning, such as social competence, vocational achieve-
ment, everyday living skills, and self-care.  In the cur-
rent paper, we review domains of disability in schizophre-
nia, as well as methods for assessing individual disability.
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Individuals with schizophrenia exhibit functional disability across a wide array of domains.  These patients 
experience impairments in their social competence, vocational aptitude, everyday living skills, and self-care 
abilities, which in the majority of patients are severe enough to prevent the return to independent living, 
even after hallmark symptoms such as hallucinations and delusions are remitted.  Unfortunately, assessment 
of the magnitude of disability in individual patients is hindered by several factors, such as reduced capabil-
ity in the area of self-evaluation and inaccuracies in self-report, as well as the presence of potential contrib-
uting variables such as depression and poor self-esteem.  Furthermore, additional barriers to recovery exist, 
such as fear of losing disability payments and factors such as discrimination.  Performance-based measures 
of functioning are new and promising instruments for assessing the competencies of patients and address 
many of the problems with other methods of assessing disability.  These measures could greatly aid clini-
cians in understanding the schizophrenia disease and recovery process, expanding treatment goals beyond 
the currently targeted positive and negative symptoms.
Abstract
Key Words:  Schizophrenia,  Disability,  Functional Outcome,  Recovery,  
Performance-Based Assessments
Functional Disability as the Core 
of Schizophrenia
 Over the last decade, the World Health Organization 
has changed its perspective on evaluating disability from 
focusing on the rate of mortality caused by the disease to 
other factors reflecting morbidity of illness, such as reduced 
quality of life and impaired engagement in activities.  This 
shift has underscored the chronic burden schizophrenia 
creates for patients, caregivers, and society.  The direct cost 
of treating schizophrenia has risen from $44 billion (1) to 
$62.7 billion (2) over the last decade.  The indirect cost of 
the disability associated with schizophrenia is approximately 
another $32 billion (2).  The social and emotional costs of 
the illness are more difficult to quantify, particularly with 
an economic model.  In fact, schizophrenia has been char-
acterized as the most disabling of all mental illnesses (3). 
Unfortunately, although pharmacological advances have 
been effective at treating positive and negative symptoms of 
schizophrenia (4), the rate of true recovery from the illness, 
defined by a return to independent living, remains relatively 
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unchanged from what it was a century ago (5).  In addition, 
evidence has emerged suggesting that the functional dis-
ability of individuals with schizophrenia is in fact, a heri-
table trait.  For example, Kendler et al. (6) found that among 
relatives of individuals with schizophrenia, the relative odds 
ratio of having occupational dysfunction (OR=3.4),  com-
pared to relatives of healthy individuals, was greater than the 
odds ratio for having positive schizotypy (OR=1.93), a trait 
that is almost universally acknowledged to run in families of 
individuals with schizophrenia.  Thus, functional disability 
within this population is not only severe, but it also appears 
to be heritable, suggesting that it is, in fact, a core aspect of 
the schizophrenia illness.
Domains of Functional Disability in 
Schizophrenia
 The functional disability of schizophrenia is also perva-
sive and is present across a wide range of domains.  Individ-
uals with schizophrenia demonstrate impairments in their 
social outcomes, vocational achievement, everyday living 
skills, and self-care. 
Social Outcomes  
 Individuals with schizophrenia exhibit severe deficits 
in their social functioning (7, 8).  Individuals with schizo-
phrenia are frequently isolated from others and have been 
found to have smaller social networks than control subjects 
(9, 10).  When individuals with schizophrenia do communi-
cate with others, they frequently have difficulty maintaining 
appropriate conversations and expressing their needs and 
feelings (11, 12).  In addition, individuals with schizophre-
nia frequently fail to achieve major social milestones, such 
as getting married.  For example, in one study of over 1,400 
individuals with schizophrenia, only 12% were married (13). 
In fact, almost two-thirds of individuals with schizophrenia 
are unable to fulfill basic social roles such as spouse or par-
ent (11).  
Vocational Achievement  
 Rates of competitive employment for individuals with 
schizophrenia are estimated to be approximately 20% (14), 
and, even with optimal support, employment rates for indi-
viduals with schizophrenia only rise to about 60% (15).  In 
addition, although individuals with schizophrenia are fre-
quently able to obtain employment while participating in 
supportive employment programs, many patients lose these 
jobs once the employment services cease (16).  Many indi-
viduals with schizophrenia, in addition, received less educa-
tion than would be expected given other demographic vari-
ables (10), which unfortunately may impede their abilities 
to gain employment during periods of symptoms remission 
(13).  
Everyday Living Skills  
 Individuals with schizophrenia also experience prob-
lems completing tasks that require the use of everyday liv-
ing skills, such as cooking, cleaning, money management, 
and using public transportation (17-20).  Few individuals 
with schizophrenia are able to live independently.  In fact, 
one large study of individuals with schizophrenia found that 
only 8% were living on their own and responsible for pay-
ment for their accommodations (21).  
Self-Care  
 Individuals with schizophrenia experience many prob-
lems with self-care, most notably related to their poor medi-
cation adherence.  Non-compliance for antipsychotic treat-
ment in this population is estimated at approximately 50% 
(22).  In addition, individuals with schizophrenia rarely seek 
out preventative health care, even if it is available to them. 
For example, McCarthy et al. (23) found that for veterans 
with psychosis, distance to medical care facilities was a ma-
jor barrier to receiving preventative treatment.  While indi-
viduals with other serious mental illness overcame this ob-
stacle by scheduling multiple appointments on the same day, 
individuals with schizophrenia did not.  In addition, chronic 
patients appear to have worse self-care than less chronic pa-
tients (24).
Methods for Assessing Functional 
Disabilities
 In the research literature, several domains have emerged 
for understanding the disability of individuals with schizo-
phrenia.  These include self-report, informant report, ob-
servational ratings, achievement of major milestones, and 
performance-based measures of functional skills.  Although 
there are benefits to all of these, many also have drawbacks.  
Self-Report  
 Self-report is the standard method of assessing pa-
tient progress in clinical settings as providers routinely ask 
patients about their progress.  This method, which is also 
widely used in research settings, has several advantages.  Pa-
tients frequently have sole access to some aspects of the in-
formation that is useful in assessing disability.  In addition, 
patients are theoretically able to self-report subjective infor-
mation that may be difficult for an outsider to determine, 
such as mood state and motivation.
 Unfortunately, individuals with schizophrenia are noto-
riously poor informants as they frequently exhibit limited 
awareness of their psychotic symptoms (25).  Furthermore, 
in one study correlations between individuals with schizo-
phrenia self-reports about cognitive deficits and their neu-
ropsychological performance were almost zero, while cor-
relations between informants’ ratings of cognitive deficits 
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and patients’ neuropsychological performance was much 
higher, r=0.40 (26).  Additionally, case managers’ ratings of 
functional outcomes were also more strongly correlated with 
performance-based measures of functional capacity than 
patients’ self-ratings (27).  In this study, patient’s self-reports 
were consistently uncorrelated with case manager reports of 
everyday outcomes, such as employment and residential in-
dependence.
Informant Report 
 Informant reports have several advantages over self-
report.  First, an informant report tends to be more objec-
tive than self-report.  In addition, informants generally do 
not exhibit the same degree of lack of insight and cognitive 
impairments, such as problems with attention and memory, 
frequently found in individuals with schizophrenia (28).  Fi-
nally, obtaining information from multiple informants could 
provide a broad view of the individual’s functioning.
 Informant reports, however, are not without their limi-
tations.  Many individuals with schizophrenia lack a close 
family member or friend who can serve as a reliable infor-
mant (29).  Additionally, caregivers may not have access to 
all behavior that is important for assessing disability.  Care-
givers may also exhibit their own biases that prevent them 
from answering honestly or accurately.  For example, care-
givers may be afraid that if they provide positive ratings, pa-
tients may lose disability or medical benefits.  Informants 
also may lack an objective understanding of what constitutes 
improvement or decline.  For example, caregivers may not 
have enough training or knowledge of illness factors to pro-




 Observation ratings also have many important ad-
vantages.  Trained observers are objective and skilled, and 
therefore are most likely to provide a valid description of 
behaviors of interest.  Furthermore, observer ratings allow 
an objective comparison between patients.  They also allow 
for the accurate assessment of changes within patients over 
time, as objective observers may identify subtle improve-
ments not apparent to patients or caregivers.
 Observational ratings also have their drawbacks, the 
first of which is their practicality.  Behavior of interest may 
occur infrequently and, therefore, in observing a patient for 
a short amount of time one might miss it.  In addition, ob-
servers can be very intrusive, and their presence can increase 
the social stigma already experienced by these patients.  
Assessing Major Milestones  
 Tracking the successful attainment of major milestones 
achieved by individuals with schizophrenia is an important 
aspect of understanding disability.  For example, it is very 
informative to know if individuals with schizophrenia 
marry, transition to independent living, or obtain a degree. 
Unfortunately, these milestones are rarely achieved by 
individuals with schizophrenia and thus lack practicality as 
a measurement tool to assess treatment progress. Further, 
these milestones require time and effort for achievement in 
the general population.  It would be very unlikely that a short-
term follow-up study of achievement of these milestones in 
healthy individuals would find a high rate of change in a 
typical six-week study resembling a clinical treatment trial.  
Performance-Based Measures of 
Functional Skills  
 Performance-based measures of functional skills are 
laboratory-based assessments during which participants are 
asked to actually perform everyday tasks such as writing a 
check or calling a friend to arrange a meeting.  Performance-
based measures, unlike other assessments, do not require 
participants to be accurate with their self-report and are far 
more cost efficient and practical than in vivo observations. 
They also do not require the assessor to wait for the spon-
taneous performance, thus the behavior of interest can be 
reliably assessed without a great time-cost for the examiner. 
Finally, these measures allow for the assessment of an indi-
vidual’s capabilities, rather than simply waiting to measure 
what the individual does.  These measures are gaining wide-
spread acceptance in the research literature (see reference 
#30 for a review of several performance-based measures), 
but at present they are rarely used in clinical practice.
 Performance-based measures of functioning for indi-
viduals with schizophrenia are available to assess most of 
the domains of disability in this population (see Table 1 for 
a summary of several promising performance-based mea-
sures). For example, The UCSD Performance-Based Skills 
Assessment (UPSA; 31) is an office-based test measuring the 
competence of individuals with schizophrenia at performing 
day-to-day tasks in five domains: household chores, commu-
nication, finance, transportation, and planning recreational 
activities. It has been found to have excellent reliability and 
test-retest reliability, and to be highly sensitive to the differ-
ence between both individuals with schizophrenia and con-
trols (31). The Social Skills Performance Assessment (SSPA; 
12), on the other hand, is a performance-based test designed 
to measure the social competence of individuals with schizo-
phrenia. It consists of two role-played scenes: one scene in 
which the subject is asked to greet a new neighbor (the in-
terviewer) and one scene in which the subject telephones 
his landlord (the interviewer) about a leak. Participants are 
rated in eight categories, including interest/disinterest, flu-
ency, clarity, focus, affect, grooming, and negotiation ability. 
The SSPA successfully distinguishes between patients and 
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normal controls and has been found to have excellent inter-
rater reliability and good test-retest reliability. Scores have 
been shown to correlate with negative symptoms, cognitive 
deficits, and health-related quality of well being, but not with 
positive symptoms or degree of depression (12). There are 
also measures of vocational competence, such as COMPASS 
Lite (Valpar International Corporation), a shortened version 
of Valpar’s Computerized Assessment (COMPASS) module. 
Functional Disability in Schizophrenia 
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tional skills as they 
relate to jobs and 
training programs, 
using the rating 
system of the Re-
vised Handbook for 
Analyzing Jobs and 
the Dictionary of 
Occupational Titles. 
Output includes 
both the number 
and complexity of 
jobs for which the 
individual is cur-
rently qualified.  
 Thus, perfor-
mance-based as-
sessments have the 
flexibility to reliably 
and validly mea-
sure an individual’s
competence without many of the drawbacks associated with 
other methods for assessing aspects of disability.  In addition, 
these measures are available to assess functioning across a 
range of areas that are commonly associated with disability 
in schizophrenia.
The Distinction between 
Competence and Performance
 A major issue in the interpretation of functional disabil-
ity in schizophrenia is that factors other than ability or com-
petence (what one can do) can have an impact on real-world 
performance (what one does).  Treatments aimed at reduc-
ing disability generally target an individual’s competence, for 
example, by teaching individuals with schizophrenia social 
skills or job skills.  However, they are aimed at real-world 
performance, such as making a friend or obtaining a job, 
which may require other opportunities, motivations, or skill 
sets.  Unfortunately, there are a host of variables that inter-
vene between competence and performance, such as depres-
sion, motivation, anxiety, fear of losing disability payments, 
and discrimination, to name a few.  Improving an individu-
al’s competence is a necessary first step in reducing disability, 
but it may not be sufficient in changing performance in most 
or all cases.  Thus, treatments aimed at reducing disability 
Non-Competence Factors Affecting  
Performance
 There are several factors that could potentially impact 
performance of tasks related to disability beyond an individ-
ual’s ability to engage in those activities.  For example, cog-
nitive symptoms appear to be among the best predictors of 
social competence and community functioning (13).  In par-
ticular, verbal memory ability appears to be closely related to 
community functioning (28), as are attention, speed, verbal 
learning, and executive functioning (32).  However, directly 
relevant to this point is the recent finding by Rosenheck et al. 
(13) indicating that while cognitive performance was corre-
lated with occupational status in people with schizophrenia, 
racial and disability status, which are not realistic treatment 
targets, have a much larger impact.  In fact, although there 
appears to be a clear relationship between cognitive impair-
must target both the 
individual’s ability 
to engage in tasks, 
and whether or 
not the individual 
actually does per-
form these tasks. 
By measuring only 
real-world perfor-
mance one might 
miss potential 
gains in the set of 
skill competencies, 
which are impor-
tant for the even-
tual deployment of 
behavior, as well as 





in the individual’s 
case.
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ment and real-world disability, some abilities share only 10% 
of the variance in everyday outcomes (28).  
 Thus, disability is influenced by a host of other factors, 
some more amenable to change than others.  Individuals 
with schizophrenia, as noted above, rarely achieve mile-
stones such as obtaining a job or marrying.  Thus, they fre-
quently have low expectations for success.  In addition, indi-
viduals with schizophrenia frequently experience depressive 
episodes (33).  In fact, it has been estimated that as many as 
75% of individuals with schizophrenia experience symptoms 
of depression (33).  Depressive symptoms, which have been 
found to occur in individuals with schizophrenia across the 
lifespan at first episode (34) and in late life (35), may also 
perpetuate disability within this population.  McGurk et 
al. (36) recently found that individuals with schizophrenia 
treated in a program that combined supportive employment 
and cognitive rehabilitation worked more hours for better 
wages, and also demonstrated lower scores on measures of 
depression and autistic preoccupation.  Thus, having success 
in treatment and in the real world appears to have a benefi-
cial impact on both an individual’s expectations and his or 
her quality of life.  Unfortunately, obtaining the first experi-
ence of success is not an easily obtainable goal for individu-
als with schizophrenia.
 In addition, individuals with schizophrenia demon-
strate a wide array of cognitive impairments (28) which im-
pacts their ability to successfully deploy skills in real world 
settings.  They also demonstrate a focal impairment in their 
ability to self-monitor, often referred to as “meta-cognition” 
(37, 38), making it difficult to self-monitor and adjust behav-
ior as needed in both social and occupational settings.  Ad-
ditionally, individuals with schizophrenia may not be able 
to accurately assess whether tasks will be challenging and, 
therefore, will require assistance.  
 Finally, the maintenance of disability in schizophrenia 
is also affected by practical considerations, such as concerns 
over losing disability income or medical benefits.  Rosen-
heck et al. (13) found that individuals who received disabil-
ity payments were less likely to be competitively employed 
than those who did not.  Individuals with schizophrenia 
who work rarely make enough money to support themselves 
(39); however, earning enough money to lose disability and 
medical benefits may be a very real concern (13).
Suggestions for Clinicians
 Functional disability is clearly an important aspect of 
the schizophrenia disease process.  However, standard clini-
cal care for individuals with schizophrenia typically focuses 
on reducing symptoms of psychosis rather than understand-
ing and treating disability.  We, therefore, believe that assess-
ing an individual’s disability status should be an integral as-
pect of treatment.  As noted above, current treatments very 
effectively target the psychotic symptoms of schizophrenia, 
symptoms that are clearly disruptive and unwanted.  Un-
fortunately, though, effective treatment of psychosis rarely 
translates into disability reduction.  Numerous studies (for 
a recent review, see reference #32) have demonstrated that 
the cross-sectional severity of positive symptoms is a poor 
predictor of functional outcome. Thus, although pharma-
cological interventions have often succeeded in treating the 
positive symptoms of schizophrenia (4), there has been a 
failure to translate symptom reduction into improved work 
and social functioning (28, 40, 41).  It is important to keep 
in mind that for individuals with schizophrenia reduction of 
symptoms is vastly different from illness recovery. 
 We also believe that obtaining adequate data is crucial 
to successfully treating disability within this population. 
While we acknowledge that it is important to obtain infor-
mation about patients’ performance from patients them-
selves, as well as from caregivers, we caution that one cannot 
assume that the information is correct.  Biases inherent in 
self-report and in caregiver ratings should always be kept in 
mind.   For instance, patients with schizophrenia appear to 
show “depressive realism,” in that patients with more severe 
depression (although still not to the extent of meeting diag-
nostic criteria for major depression) were actually more ac-
curate at self-evaluation than those with less depression (27). 
This data suggests that accuracy of self-report might vary 
over time, changing along with the severity of concurrent 
depression.  However, related to this issue is the finding that 
more severe depression is associated with relatively poorer 
real-world outcomes than would be expected from scores on 
competence measures (27).  Thus, depression may increase 
accuracy of self-evaluation but suppress the likelihood that 
patients actually live up to their potential.
 In addition, we believe that it is just as important to un-
derstand an individual’s competence as it is to understand his 
or her real-world performance.  Performance under optimal 
conditions is the limiting factor for real-world outcomes. 
Improved competence is a necessary part of improving per-
formance, and examining progress in competence through-
out treatment is, therefore, an important part of evaluating 
its effectiveness.  Furthermore, numerous factors intervene 
between competence and performance.  If one has a valid as-
sessment of an individual’s competence, this can be used to 
examine barriers to real-world performance of these skills.
 Finally, it is crucial to eliminate extraneous barriers to 
disability reduction whenever possible.  Although some fac-
tors that relate to the maintenance of disability may not be 
appropriate treatment targets, several factors are.  In addi-
tion to pharmacological treatment of psychosis, therefore, 
we propose that clinicians carefully attend to secondary ill-
nesses such as depressive symptomatology and anxiety.  The 
widespread success of supportive employment programs in 
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conjunction with skills training programs for individuals 
with schizophrenia (16, 35) suggests that disability reduc-
tion is possible with the proper support and when factors 
such as poor expectations and problems with self-monitor-
ing are addressed.   Thus, psychosocial treatments targeting 
self-esteem and expectations, as well as residual effects from 
prior discrimination and stigmatization, could help reduce 
many barriers to disability reduction beyond an individual’s 
competence.
Conclusions
 Individuals with schizophrenia experience significant 
disability across a wide range of arenas, including social 
competence, vocational achievement, everyday living skills, 
and self-care.  This disability, which is responsible for great 
cost to patients, caregivers, and society, appears to be a core 
feature of schizophrenia as it is pervasive across domains of 
functioning and across individual patients.  We believe that 
performance-based measures of functioning are the most 
appropriate means of assessing disability in clinical settings 
as they provide vital information about an individual’s skill 
competence.  As several factors intervene between com-
petence and performance, understanding an individual’s 
competence allows for a more accurate understanding of 
barriers to disability reduction and can aid in more effective 
treatment planning.  Assessing functional disability in the 
schizophrenia population is vital for providing appropriate 
care with functional recovery, rather than symptom remis-
sion, as its goal. 
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